WO2024231499 - COMBINATIONS OF SHORT GENETIC VARIANTS IN THE DIAGNOSIS OF ALZHEIMER DISEASE
National phase entry is expected:
Publication Number
WO/2024/231499
Publication Date
14.11.2024
International Application No.
PCT/EP2024/062838
International Filing Date
08.05.2024
Title **
[English]
COMBINATIONS OF SHORT GENETIC VARIANTS IN THE DIAGNOSIS OF ALZHEIMER DISEASE
[French]
COMBINAISONS DE VARIANTS GÉNÉTIQUES COURTS UTILISÉES DANS LE DIAGNOSTIC DE LA MALADIE D'ALZHEIMER
Applicants **
VIB VZW
Suzanne Tassierstraat 1
9052 Gent, BE
UNIVERSITEIT ANTWERPEN
Prinsstraat 13
2000 Antwerpen, BE
Inventors
MANCUSO, Renzo
c/o VIB-UAntwerp Center for Molecular Neurology
Universiteitsplein 1
2610 Antwerpen, BE
SLEEGERS, Kristel
c/o VIB-UAntwerp Center for Molecular Neurology
Universiteitsplein 1
2610 Antwerpen, BE
LEGUIA FAURO, Gonzalo
c/o VIB-UAntwerp Center for Molecular Neurology
Universiteitsplein 1
2610 Antwerpen, BE
WATZEELS, Tijs
VIB-UAntwerp Center for Molecular Neurology
Universiteitsplein 1
2610 Antwerpen, BE
Priority Data
23172645.6
10.05.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2350 | |
| EPO | Filing, Examination | 8397 | |
| Japan | Filing | 594 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 5185 |
Total: 17101 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention relates to combinations of Alzheimer disease risk loci, more in particular short genetic variant loci (SGVs). Combinations of such SGVs were identified that are significantly and synergistically pathogenic. Applications of these combinations, such as diagnostic applications, are included as well.[French]
L'invention concerne des combinaisons de loci de risque de maladie d'Alzheimer, plus particulièrement de loci de variants génétiques (SGV) courts . On a identifié des combinaisons de tels SGV qui sont pathogènes de manière significative et synergique. L'invention concerne également des applications de ces combinaisons, telles que des applications de diagnostic.